UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Phase II Open Label Study of Anakinra in Intravenous Immunoglobulin–Resistant Kawasaki Disease

Arthritis & rheumatology (Hoboken, N.J.), 2021-01, Vol.73 (1), p.151-161

2021

Volltextzugriff (PDF)

Kawasaki disease: insights into pathogenesis and approaches to treatment

Nature reviews. Rheumatology, 2015-08, Vol.11 (8), p.475-482

2015

Volltextzugriff (PDF)

Kawasaki Disease at 50 Years

JAMA pediatrics, 2016-11, Vol.170 (11), p.1093

2016

Volltextzugriff (PDF)

Myocarditis and Kawasaki disease

International journal of rheumatic diseases, 2018-01, Vol.21 (1), p.45-49

2018

Volltextzugriff (PDF)

Assessment of Platelet Thrombus Formation under Flow Conditions in Patients with Acute Kawasaki Disease

The Journal of pediatrics, 2020-11, Vol.226, p.266-273

2020

Volltextzugriff (PDF)

Novel Risk Assessment Tool for Immunoglobulin Resistance in Kawasaki Disease: Application Using a Random Forest Classifier

The Pediatric infectious disease journal, 2017-09, Vol.36 (9), p.821-826

2017

Volltextzugriff (PDF)

Evolution of laboratory values in patients with Kawasaki disease

The Pediatric infectious disease journal, 2011-12, Vol.30 (12), p.1022-1026

2011

Volltextzugriff (PDF)

Relationship between ocular manifestations, laboratory findings, echocardiographic findings, and intravenous immunoglobulin resistance in Kawasaki disease

Pediatric rheumatology online journal, 2024-05, Vol.22 (1), p.50-50, Article 50

2024

Volltextzugriff (PDF)

Effective infliximab therapy for the early regression of coronary artery aneurysm in Kawasaki disease

International journal of cardiology, 2018-11, Vol.271, p.317-321

2018

Volltextzugriff (PDF)

The role of corticosteroids in the treatment of Kawasaki disease

Expert review of anti-infective therapy, 2020-02, Vol.18 (2), p.155-164

2020

Volltextzugriff (PDF)

High dose Anakinra for treatment of severe neonatal Kawasaki disease: a case report

Pediatric rheumatology online journal, 2014-07, Vol.12 (1), p.26-26, Article 26

2014

Volltextzugriff (PDF)

Kawasaki Disease: Pathophysiology, Clinical Manifestations, and Management

Current rheumatology reports, 2014-06, Vol.16 (6), p.423-423, Article 423

2014

Volltextzugriff (PDF)

Effectiveness of lopinavir/ritonavir on COVID-19-related pneumonia in a child with COVID-19-associated Kawasaki disease

Cardiology in the young, 2021-03, Vol.31 (3), p.507-510

2021

Volltextzugriff (PDF)

Management of coronary artery aneurysms using abciximab in children with Kawasaki disease

International journal of cardiology, 2016-10, Vol.220, p.65-69

2016

Volltextzugriff (PDF)

Prognostic Significance of QT Interval Dispersion in the Response to Intravenous Immunoglobulin Therapy in Kawasaki Disease

Circulation Journal, 2017/03/24, Vol.81(4), pp.537-542

2017

Volltextzugriff (PDF)

Efficacy and limitation of infliximab treatment for children with Kawasaki disease intractable to intravenous immunoglobulin therapy: report of an open-label case series

Journal of rheumatology, 2012-04, Vol.39 (4), p.864-867

2012

Volltextzugriff (PDF)

Kawasaki disease: What is the epidemiology telling us about the etiology?

International journal of infectious diseases, 2005-07, Vol.9 (4), p.185-194

2005

Volltextzugriff (PDF)

Infliximab treatment for refractory Kawasaki syndrome

The Journal of pediatrics, 2005-05, Vol.146 (5), p.662-667

2005

Volltextzugriff (PDF)

Myocardial Infarction Associated with Kawasaki Disease in Adult Man: Case Report and Review of Literature

The American journal of medicine, 2015-03, Vol.128 (3), p.e1-e3

2015

Volltextzugriff (PDF)

Atorvastatin Safety in Kawasaki Disease Patients With Coronary Artery Aneurysms

Pediatric cardiology, 2014, Vol.35 (1), p.89-92

2014

Volltextzugriff (PDF)

Responsiveness to intravenous immunoglobulins and occurrence of coronary artery abnormalities in a single-center cohort of Italian patients with Kawasaki syndrome

Rheumatology international, 2010-04, Vol.30 (6), p.841-846

2010

Volltextzugriff (PDF)

Reverse regulation of soluble receptor for advanced glycation end products and proinflammatory factor resistin and S100A12 in Kawasaki disease

Arthritis research & therapy, 2012-11, Vol.14 (6), p.R251-R251, Article R251

2012

Volltextzugriff (PDF)

High incidence of adrenal suppression in children with Kawasaki disease treated with intravenous immunoglobulin plus prednisolone

Endocrine Journal, 2015, Vol.62(2), pp.145-151

2015

Volltextzugriff (PDF)

Evaluation of clinical characteristics of Kawasaki syndrome and risk factors for coronary artery abnormalities among children in Denmark

Acta Paediatrica, 2013-04, Vol.102 (4), p.385-390

2013

Volltextzugriff (PDF)

Acute Kawasaki disease : Not just for kids

Journal of general internal medicine : JGIM, 2007-05, Vol.22 (5), p.681-684

2007

Volltextzugriff (PDF)

1 – 25 von 97

Suche als RSS-Feed

Aktive Filter

ThemaMucocutaneous Lymph Node Syndrome - Drug Therapy

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(88)
Mit Volltextzugriff
(76)

Publikationsform

Artikel
(96)
magazinearticle
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(96)
Life Sciences & Biomedicine
(78)
Science & Technology
(78)
Mucocutaneous Lymph Node Syndrome - Physiopathology
(77)
Male
(70)
Child, Preschool
(63)
Female
(62)
Kawasaki Disease
(55)
Child
(53)
Infant
(51)
Immunoglobulins, Intravenous - Therapeutic Use
(50)
Mucocutaneous Lymph Node Syndrome - Diagnosis
(41)
Mucocutaneous Lymph Node Syndrome - Complications
(36)
Pediatrics
(35)
Aspirin - Therapeutic Use
(27)
Treatment Outcome
(25)
Biological And Medical Sciences
(24)
Medical Sciences
(24)
Cardiovascular System & Cardiology
(21)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Phase II Open Label Study of Anakinra in Intravenous Immunoglobulin–Resistant Kawasaki Disease

Kawasaki disease: insights into pathogenesis and approaches to treatment

Kawasaki Disease at 50 Years

Myocarditis and Kawasaki disease

Assessment of Platelet Thrombus Formation under Flow Conditions in Patients with Acute Kawasaki Disease

Novel Risk Assessment Tool for Immunoglobulin Resistance in Kawasaki Disease: Application Using a Random Forest Classifier

Evolution of laboratory values in patients with Kawasaki disease

Relationship between ocular manifestations, laboratory findings, echocardiographic findings, and intravenous immunoglobulin resistance in Kawasaki disease

Effective infliximab therapy for the early regression of coronary artery aneurysm in Kawasaki disease

The role of corticosteroids in the treatment of Kawasaki disease

High dose Anakinra for treatment of severe neonatal Kawasaki disease: a case report

Kawasaki Disease: Pathophysiology, Clinical Manifestations, and Management

Effectiveness of lopinavir/ritonavir on COVID-19-related pneumonia in a child with COVID-19-associated Kawasaki disease

Management of coronary artery aneurysms using abciximab in children with Kawasaki disease

Prognostic Significance of QT Interval Dispersion in the Response to Intravenous Immunoglobulin Therapy in Kawasaki Disease

Efficacy and limitation of infliximab treatment for children with Kawasaki disease intractable to intravenous immunoglobulin therapy: report of an open-label case series

Kawasaki disease: What is the epidemiology telling us about the etiology?

Infliximab treatment for refractory Kawasaki syndrome

Myocardial Infarction Associated with Kawasaki Disease in Adult Man: Case Report and Review of Literature

Atorvastatin Safety in Kawasaki Disease Patients With Coronary Artery Aneurysms

Responsiveness to intravenous immunoglobulins and occurrence of coronary artery abnormalities in a single-center cohort of Italian patients with Kawasaki syndrome

Reverse regulation of soluble receptor for advanced glycation end products and proinflammatory factor resistin and S100A12 in Kawasaki disease

High incidence of adrenal suppression in children with Kawasaki disease treated with intravenous immunoglobulin plus prednisolone

Evaluation of clinical characteristics of Kawasaki syndrome and risk factors for coronary artery abnormalities among children in Denmark

Acute Kawasaki disease : Not just for kids

Aktive Filter

Suchergebnisse filtern